UK-SH Universitätsklinikum Schleswig-Holstein

Autor	Titel	Journal
Heidebrecht HJ, Claviez A, Kruse ML, Pollmann M, Buck F, Harder S, Tiemann M, Dorffel W, Parwaresch R.	Characterization and Expression of CT45 in Hodgkin's Lymphoma.	Clin Cancer Res. 2006 Aug 15;12(16):4804-11.
Pollmann M, Parwaresch R, Adam-Klages S, Kruse ML, Buck F, Heidebrecht HJ.	Human EML4, a novel member of the EMAP family, is essential for microtubule formation.	Exp Cell Res. 2006
Gesk S, Klapper W, Martin-Subero JI, Nagel I, Harder L, Fu K, Bernd HW, Weisenburger DD, Parwaresch R, Siebert R.	A chromosomal translocation in cyclin D1-negative/cyclin D2-positive mantle cell lymphoma fuses the CCND2 gene to the IGK locus.	Blood. 2006 Aug 1;108(3):1109-10.
Hummel M, Bentink S, Berger H, Klapper W, Wessendorf S, Barth TF, Bernd HW, Cogliatti SB, Dierlamm J, Feller AC, Hansmann ML, Haralambieva E, Harder L, Hasenclever D, Kuhn M, Lenze D, Lichter P, Martin-Subero JI, Moller P, Muller-Hermelink HK, Ott G, Parwaresch RM, Pott C, Rosenwald A, Rosolowski M, Schwaenen C, Sturzenhofecker B, Szczepanowski M, Trautmann H, Wacker HH, Spang R, Loeffler M, Trumper L, Stein H, Siebert R; Molecular Mechanisms in Malignant Lymphomas Network Project of the Deutsche Krebshilfe.	A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling.	N Engl J Med. 2006 Jun 8;354(23):2419-30.
Burkhardt B, Bruch J, Zimmermann M, Strauch K, Parwaresch R, Ludwig WD, Harder L, Schlegelberger B, Mueller F, Harbott J, Reiter A. Related Articles, Links	Loss of heterozygosity on chromosome 6q14-q24 is associated with poor outcome in children and adolescents with T-cell lymphoblastic lymphoma.	Leukemia.2006 Aug; 20(8):1422-9. Epub 2006 Jun 1.
Woessmann W, Peters C, Lenhard M, Burkhardt B, Sykora KW, Dilloo D, Kremens B, Lang P, Fuhrer M, Kuhne T, Parwaresch R, Ebell W, Reiter A.	Allogeneic haematopoietic stem cell transplantation in relapsed or refractory anaplastic large cell lymphoma of children and adolescents--a Berlin-Frankfurt-Munster group report.	Br J Haematol. 2006 Apr;133(2):176-82.
Klapper W, Szczepanowski M, Heidorn K, Muschen M, Liedtke S, Sotnikova A, Andersen NS, Greeve J, Parwaresch R.	Immunoglobulin class-switch recombination occurs in mantle cell lymphomas.	J Pathol. 2006 Jun;209(2):250-7.
Oschlies I, Klapper W, Zimmermann M, Krams M, Wacker HH, Burkhardt B, Harder L, Siebert R, Reiter A, Parwaresch R.	Diffuse large B-cell lymphoma in pediatric patients belongs predominantly to the germinal-center type B-cell lymphomas: a clinicopathologic analysis of cases included in the German BFM (Berlin-Frankfurt-Munster) Multicenter Trial.	Blood. 2006 May 15;107(10):4047-52.
Schrader C, Janssen D, Meusers P, Brittinger G, Siebmann JU, Parwaresch R, Tiemann M.	: a new prognostic marker in mantle cell lymphoma.	Eur J Haematol. 2005 Dec;75(6):498-504.
Kosari F, Daneshbod Y, Parwaresch R, Krams M, Wacker HH. Related Articles, Links	Lymphomas of the female genital tract: a study of 186 cases and review of the literature.	Am J Surg Pathol. 2005 Nov;29(11):1512-20. Review.
Schrader C, Janssen D, Klapper W, Siebmann JU, Meusers P, Brittinger G, Kneba M, Tiemann M, Parwaresch R.	Minichromosome maintenance protein 6, a proliferation marker superior to Ki-67 and independent predictor of survival in patients with mantle cell lymphoma.	Br J Cancer. 2005 Oct 17;93(8):939-45.
Burkhardt B, Zimmermann M, Oschlies I, Niggli F, Mann G, Parwaresch R, Riehm H, Schrappe M, Reiter A; BFM Group.	The impact of age and gender on biology, clinical features and treatment outcome of non-Hodgkin lymphoma in childhood and adolescence.	Br J Haematol. 2005 Oct;131(1):39-49.
Tiemann M, Schrader C, Klapper W, Dreyling MH, Campo E, Norton A, Berger F, Kluin P, Ott G, Pileri S, Pedrinis E, Feller AC, Merz H, Janssen D, Hansmann ML, Krieken H, Moller P, Stein H, Unterhalt M, Hiddemann W, Parwaresch R; European MCL Network.	Histopathology, cell proliferation indices and clinical outcome in 304 patients with mantle cell lymphoma (MCL): a clinicopathological study from the European MCL Network.	Br J Haematol. 2005 Oct;131(1):29-38.
Koch P, Probst A, Berdel WE, Willich NA, Reinartz G, Brockmann J, Liersch R, del Valle F, Clasen H, Hirt C, Breitsprecher R, Schmits R, Freund M, Fietkau R, Ketterer P, Freitag EM, Hinkelbein M, Heinecke A, Parwaresch R, Tiemann M.	Treatment results in localized primary gastric lymphoma: data of patients registered within the German multicenter study (GIT NHL 02/96).	J Clin Oncol. 2005 Oct 1;23(28):7050-9.
Hiddemann W, Kneba M, Dreyling M, Schmitz N, Lengfelder E, Schmits R, Reiser M, Metzner B, Harder H, Hegewisch-Becker S, Fischer T, Kropff M, Reis HE, Freund M, Wormann B, Fuchs R, Planker M, Schimke J, Eimermacher H, Trumper L, Aldaoud A, Parwaresch R, Unterhalt M.	Frontline therapy with rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) significantly improves the outcome for patients with advanced-stage follicular lymphoma compared with therapy with CHOP alone: results of a prospective randomized study of the German Low-Grade Lymphoma Study Group.	Blood. 2005 Dec 1;106(12):3725-32.
Anlauf M, Schafer MK, Schwark T, von Wurmb-Schwark N, Brand V, Sipos B, Horny HP, Parwaresch R, Hartschuh W, Eiden LE, Kloppel G, Weihe E. Related Articles, Links	Vesicular monoamine transporter 2 (VMAT2) expression in hematopoietic cells and in patients with systemic mastocytosis.	J Histochem Cytochem. 2006 Feb;54(2):201-13.
Gesk S, Gascoyne RD, Schnitzer B, Bakshi N, Janssen D, Klapper W, Martin-Subero JI, Parwaresch R, Siebert R.	ALK-positive diffuse large B-cell lymphoma with ALK-Clathrin fusion belongs to the spectrum of pediatric lymphomas.	Leukemia. 2005 Oct;19(10):1839-40. No abstract available.
Claviez A, Tiemann M, Luders H, Krams M, Parwaresch R, Schellong G, Dorffel W.	Impact of latent Epstein-Barr virus infection on outcome in children and adolescents with Hodgkin's lymphoma.	J Clin Oncol. 2005 Jun 20;23(18):4048-56.
Ruhnke M, Ungefroren H, Nussler A, Martin F, Brulport M, Schormann W, Hengstler JG, Klapper W, Ulrichs K, Hutchinson JA, Soria B, Parwaresch RM, Heeckt P, Kremer B, Fandrich F.	Differentiation of in vitro-modified human peripheral blood monocytes into hepatocyte-like and pancreatic islet-like cells.	Gastroenterology. 2005 Jun;128(7):1774-86.
Hoffmann C, Tiemann M, Schrader C, Janssen D, Wolf E, Vierbuchen M, Parwaresch R, Ernestus K, Plettenberg A, Stoehr A, Fatkenheuer G, Wyen C, Oette M, Horst HA.	AIDS-related B-cell lymphoma (ARL): correlation of prognosis with differentiation profiles assessed by immunophenotyping.	Blood. 2005 Sep 1;106(5):1762-9.
Lenz G, Dreyling M, Hoster E, Wormann B, Duhrsen U, Metzner B, Eimermacher H, Neubauer A, Wandt H, Steinhauer H, Martin S, Heidemann E, Aldaoud A, Parwaresch R, Hasford J, Unterhalt M, Hiddemann W.	Immunochemotherapy with rituximab and cyclophosphamide, doxorubicin, vincristine, and prednisone significantly improves response and time to treatment failure, but not long-term outcome in patients with previously untreated mantle cell lymphoma: results of a prospective randomized trial of the German Low Grade Lymphoma Study Group (GLSG).	J Clin Oncol. 2005 Mar 20;23(9):1984-92. Epub 2005 Jan 24.
Dreyling M, Lenz G, Hoster E, Van Hoof A, Gisselbrecht C, Schmits R, Metzner B, Truemper L, Reiser M, Steinhauer H, Boiron JM, Boogaerts MA, Aldaoud A, Silingardi V, Kluin-Nelemans HC, Hasford J, Parwaresch R, Unterhalt M, Hiddemann W.	Early consolidation by myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission significantly prolongs progression-free survival in mantle-cell lymphoma: results of a prospective randomized trial of the European MCL Network.	Blood. 2005 Apr 1;105(7):2677-84.
Woessmann W, Seidemann K, Mann G, Zimmermann M, Burkhardt B, Oschlies I, Ludwig WD, Klingebiel T, Graf N, Gruhn B, Juergens H, Niggli F, Parwaresch R, Gadner H, Riehm H, Schrappe M, Reiter A; BFM Group.	The impact of the methotrexate administration schedule and dose in the treatment of children and adolescents with B-cell neoplasms: a report of the BFM Group Study NHL-BFM95.	Blood. 2005 Feb 1;105(3):948-58.
Klapper W, Moosig F, Sotnikova A, Qian W, Schroder JO, Parwaresch R.	Telomerase activity in B and T lymphocytes of patients with systemic lupus erythematosus.	Ann Rheum Dis. 2004 Dec;63(12):1681-3.
Helfenstein A, Frahm SO, Krams M, Drescher W, Parwaresch R, Hassenpflug J.	Minichromosome maintenance protein (MCM6) in low-grade chondrosarcoma: distinction from enchondroma and identification of progressive tumors.	Am J Clin Pathol. 2004 Dec;122(6):912-8.
Schrader C, Meusers P, Brittinger G, Teymoortash A, Siebmann JU, Janssen D, Parwaresch R, Tiemann M.	Topoisomerase IIalpha expression in mantle cell lymphoma: a marker of cell proliferation and a prognostic factor for clinical outcome.	Leukemia. 2004 Jul;18(7):1200-6.
Krams M, Parwaresch R, Sipos B, Heidorn K, Harms D, Rudolph P. Related Articles, Links	Expression of the c-kit receptor characterizes a subset of neuroblastomas with favorable prognosis.	Oncogene. 2004 Jan 15;23(2):588-95.